Good Jennifer L
- SEC CIK
- 0001229245
No open-market purchases or sales filed in the past year.
Current role at each company
- RYTM Rhythm Pharmaceuticals, Inc.Directoras of Jun 25, 2026
- TRVI Trevi Therapeutics, Inc.President & CEOas of Feb 20, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Good Jennifer L as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
TRVI Trevi Therapeutics, Inc.
President & CEO5 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 25, 2025 (view filing) | Mar 21 | 4 days | Good Jennifer LPresident & CEO | SSale | −5.26K | $6.58 | −$34.6K | −2.4%213.3K after | |
| Sep 9, 2024 (view filing) | Sep 6-9 | 3 days | Good Jennifer LPresident & CEO | SSale | −6.06K | $3.03 | −$18.4K | −2.8%213.3K after | 2 lots |
| Sep 5, 2024 (view filing) | Sep 3-5 | 2 days | Good Jennifer LPresident & CEO | SSale | −55.1K | $3.09 | −$170.1K | −20.5%213.3K after | 3 lots |
| May 22, 2024 (view filing) | May 20 | 2 days | Good Jennifer LPresident & CEO | SSale | −25.0K | $2.86 | −$71.6K | −10.5%213.3K after | |
| May 14, 2024 (view filing) | May 10 | 4 days | Good Jennifer LPresident & CEO | SSale | −4.58K | $2.90 | −$13.3K | −2.1%213.3K after |
RYTM Rhythm Pharmaceuticals, Inc.
Director3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 19, 2024 (view filing) | Sep 17 | 2 days | Good Jennifer LDirector | SSale | −31.8K | $52.40 | −$1.66M | −91.4%3.00K after | 10b5-1 |
| Sep 11, 2024 (view filing) | Sep 9 | 2 days | Good Jennifer LDirector | SSale | −37.2K | $50.45 | −$1.88M | −92.5%3.00K after | 10b5-1 |
| Aug 28, 2024 (view filing) | Aug 26 | 2 days | Good Jennifer LDirector | SSale | −14.5K | $50.01 | −$725.5K | −82.9%3.00K after | 10b5-1 |